Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Notice of Extraordinary General Meeting in MyFirstApp Sweden AB (publ)

The shareholders of MyFirstApp Sweden AB (publ), corp. ID 556670-3038, are hereby invited to an extraordinary general meeting on January 11, 2024, at 09:00 AM at Birger Jarlsgatan 20, 5th floor, 114 34 Stockholm.Shareholders who wish to participate in the meeting must be entered in the printout of the share register regarding the conditions on January 3, 2024, and must notify the company of their attendance no later than January 8, 2024, in writing to BOX 164 16, 103 27 Stockholm, or by email to jesper@myfirstapp.com. The notification should include the name, personal or organization

Medivir’s partner IGM Biosciences announces strategic pipeline prioritization to extend its cash runway

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that its partner, IGM Biosciences, has communicated a strategic pipeline prioritization and reduction of workforce with the key aim of extending its cash runway in a challenging financial climate.   In the announcement by IGM, a number of its programs are impacted by this pipeline prioritization, including the combination of IGM’s DR-5 agonist, aplitabart and birinapant, which IGM licensed from

OM Pharma appoints Roch Ogier as Chief Executive Officer

OM Pharma, a global biopharmaceutical company headquartered in Switzerland, announced the appointment of Roch Ogier as Chief Executive Officer (CEO), effective January 1, 2024. He will succeed Josef Troxler, who will continue to share his expertise as Senior Advisor and Chairman of the Board of the Swiss Affiliate.Geneva, Switzerland, 6 December 2023 - OM Pharma’s Board of Directors has appointed Roch Ogier as Chief Executive Officer (CEO) with effect from January 1, 2024. Roch, currently Chief Operating Officer, brings a wealth of experience in the biotechnology field and across the

Important portfolio updates from Katalysen Ventures with aggregated positive impact on portfolio value

Today, Katalysen Ventures AB (publ) (“Katalysen”) announced important portfolio updates, with a total positive impact on the estimated total portfolio value of +10.7 MSEK (+6.7%) since last communicated portfolio value.Katalysen has decided to conduct a write-down, with a negative impact on book value of -13.6 MSEK, resulting in a -12.3 MSEK impact on Katalysen’s estimated portfolio value. This adjustment is attributable to the portfolio ventures VenturePort, Payer, and Uggla. Furthermore, Katalysen recently announced the inaugural investment of Venture Targeter AB (“Venture Targeter”),

Business Update from M.O.B.A. Network - Positive Download Trend and Development

MOBA Network proudly announces that the company's efforts over the past quarters have resulted in significant progress. With a focus on continuing to develop our platforms, we can report that Porofessor, one of our acquired platforms, has seen a substantial increase in the number of downloads since its acquisition. Porofessor has reached a total of 11.5 million downloads, with a steady growth rate of over 7,800 per day. Additionally, we observe a positive trend in revenue per user. In addition to the development of Porofessor's user base, we have been actively working on structuring and

Hunter Group ASA – Share capital increase registered

Oslo, 6 December 2023 Hunter Group ASA (the “Company”) refers to the private placement of 14,333,333 new shares (the “New Shares”), at a subscription price of NOK 1.50, raising gross proceeds of NOK 21.5 million (the “Private Placement”). The share capital increase pertaining to the issuance of the New Shares has today been registered with the Norwegian Register of Business Enterprises (Nw. Foretaksregisteret). The Company’s new share capital is NOK 1,648,061 (rounded), divided into 43,101,434 shares, each with a nominal value of NOK 0.038 (rounded). 5,500,000 New Shares will be

Multiconsult expands in Sweden through acquisition of Helm

Multiconsult (Oslo: MULTI) has strengthened its position in the Swedish market with the acquisition of Helm Connect AB and Helm Project Management by its Swedish subsidiary, Iterio AB. This strategic move enhances Iterio's capabilities, allowing the company to pursue ambitious goals and gain additional market share in Sweden.Helm is a consultancy company that provides services in project and construction management, alongside expertise in coordinating technical infrastructure within urban areas. With a team of skilled professionals dedicated to project support, the company, consisting of 17

Challengermode to Power the First-Ever Counter-Strike 2 Major in Partnership with PGL

The partnership establishes Challengermode as the Exclusive Platform Partner for the first Counter-Strike 2 major in history, hosted by PGL, a leading esports broadcaster, in Copenhagen, Denmark.Stockholm, December 6 2023: Leading esports platform Challengermode has been selected as the Exclusive Platform Partner for the historic PGL Counter-Strike 2 Copenhagen Major 2024, the first-ever Counter-Strike 2 major. Organized by PGL, this milestone tournament represents one of the most significant events in the 2024 esports calendar. Over the years, the Challengermode platform has been the

NCC appoints two new Heads of Business Areas – Helena Hed and Niklas Sparw

NCC has appointed new leaders for two business areas. Niklas Sparw will become new Head of NCC Building Sweden. He is currently division manager within NCC. Helena Hed will become Head of the new business area NCC Green Industry Transformation. She is currently CEO of the listed consulting group Projektengagemang. Both will join NCC’s Senior Management Team. Niklas Sparw and Helena Hed Niklas Sparw has worked at NCC for more than 25 years, including as head of NCC Engineering and Sustainability, and is currently Head of division within NCC Building Sweden. He has a master's

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 215 - 6 DECEMBER 2023 In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 186/23 and 187/23.   Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Stig Frederiksen, Head of Investor Relations, tel.: +45 32 71 08 55, e-mail: sfr@norden.com

Helena Hed is stepping down as CEO of Projektengagemang Sweden AB

After three years as CEO and Group CEO at Projektengagemang, Helena Hed has informed the company's board that she has chosen to resign from her position to pursue other opportunities. Helena will continue to work as the CEO of PE Teknik & Arkitektur until June 2024 to ensure a smooth transition.Helena Hed assumed the role of CEO of Projektengagemang on December 1, 2020. - I've had three fantastic years at Projektengagemang. I am proud of what we have accomplished together and look forward to following the continued journey for all employees and the company. - I want to extend my and

Director/PDMR Shareholdings

Capital for Colleagues plc / EPIC: CFCP / Market: Aquis / Sector: Financials   6 December 2023 CAPITAL FOR COLLEAGUES PLC (‘Capital for Colleagues’, ‘C4C’ or the ‘Company’)   DIRECTOR/PDMR SHAREHOLDINGS   Capital for Colleagues, the investment vehicle focused on opportunities in the Employee Owned Business (‘EOB’) sector, has been notified that C4C SIP Trustee Limited (the ‘Trustee’) has allocated a total of 22,168 existing ordinary shares of 40p each in the Company (‘Ordinary Shares’) to participants in the Company’s Share Incentive Plan (‘SIP’) at a price of 57.5p

Management changes at PostNord

Mathias Krümmel is set to leave PostNord and thus his positions of CEO of PostNord Sweden and member of the Group Leadership Team. Ylva Ekborn, who is currently Head of PostNord Accelerate and Group CEO and President of PostNord Strålfors, will take over as acting CEO of PostNord Sweden. Ylva Ekborn has been a member of PostNord’s Group Leadership Team since 2018. Annemarie Gardshol, Group CEO and President of PostNord, will take on the role of acting Head of PostNord Accelerate. Lisbet Karlsson, who is currently Country Manager for PostNord Strålfors Sweden, will become acting Group CEO and

Risk Intelligence A/S announces the launch of the new Risk Intelligence System platform

Risk Intelligence A/S (“Risk Intelligence” or "the Company") announces the launch of the new Risk Intelligence System platform, which will significantly improve client and user value and create a solid foundation for growth in annual recurring revenue.MaRisk has been the benchmark for maritime intelligence platforms since 2008 and became the Risk Intelligence System, when PortRisk was added in 2015. Whilst continued development has been done since the last major platform launch in 2016, the Company is now ready to officially unveil the 4th generation to the market after a soft launch from

Announcement regarding managers' transactions in MapsPeople A/S

MapsPeople A/S | Managers transactions Company Announcement No.  34-2023Aalborg, December 6, 2023Announcement regarding managers' transactions MapsPeople A/S has received notification pursuant to article 19 of regulation (EU) no. 596/2014 of the below transactions related to shares in MapsPeople A/S made by persons discharging managerial responsibilities and/or persons closely related with them. In addition to below transactions, FTWW ApS (closely related to a person discharging managerial responsibilities - Rasmus Mencke, board member in MapsPeople A/S) has signed 84,034 shares.

BioStock: Chordate's CSO comments on the start of the PM009 study

The first patient has now been enrolled in Chordate Medical's open pilot study PM009, which aims to evaluate the effect of the company's migraine treatment Ozilia on patients who do not respond to treatment with CGRP inhibitors and other treatment options. BioStock reached out to the company's Clinical Research & Medical Director, Jan Hermansson, to find out more about the study.Read the full article at biostock.se: https://www.biostock.se/en/2023/12/chordates-cso-comments-on-the-start-of-the-pm009-study/ This is a press release from BioStock - Connecting Innovation & Capital. https://

Fiven ASA announces applicable redemption premium for redeeming its outstanding EUR 70m bonds

As announced on 27 November 2023, Fiven ASA ("Fiven") will redeem its outstanding EUR 70,000,000 senior secured sustainability-linked floating rate bonds with ISIN SE0016075196 (the "Bonds") in advanced on 21 December 2023 (the "Redemption Date").   Fiven has met the sustainability performance target for each relevant KPI on the relevant target observation date (being 21 November 2023) and no sustainability-linked redemption premium shall therefore be paid on the Redemption Date (in accordance with Clause 9.4 (Sustainability-Linked Redemption Premium) of the terms and conditions of

Himalaya Shipping Ltd. (HSHP) – Commercial Update

Hamilton, Bermuda, December 6, 2023 In November 2023, the Company achieved average time charter equivalent (“TCE”) earnings of approximately US$33,200 per day, gross[1]. The Company’s five vessels trading on index-linked time charters earned approximately US$33,800 per day, gross, including average daily scrubber and LNG benefits of approximately US$1,300 per day. The Company’s only vessel trading on a fixed time charter earned US$30,000 per day, gross. The Baltic 5TC Capesize Index averaged US$24,003 during November 2023. The Company has agreed to convert its index linked charters

Repurchase of Outokumpu’s own shares

Outokumpu OyjStock exchange releaseDecember 6, 2023, at 9.30 am EETRepurchase of Outokumpu’s own shares On December 5, 2023, Outokumpu has completed repurchases its own shares as follows (ISIN FI0009002422): +-------+----------------+------------------------------------+----------------+|Trading|Number of shares|Weighted average price / share, EUR*|Total cost, EUR*||venue | | | |+-------+----------------+------------------------------------+----------------+|CEUX |68,505 |4.2231

STENOCARE A/S: Announcement of Exercise Price of Warrants of Series TO1

STENOCARE A/SNASDAQ FIRST NORTH GROWTH MARKET, DENMARKTICKER:  STENONOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE. This information is information that STENOCARE A/S is obliged to publish in accordance with the EU Market Abuse Regulation. The information was provided

GARO to divest a small industrial property in Gnosjö for MSEK 12, generating a minor capital gain

At the start of the year, the GARO Electrification business area relocated its operations in Sweden to purpose-designed premises in Hillerstorp. The project included the divestment of a small property in Gnosjö. The property has now been divested at a value of MSEK 12 to ZAL-produkter AB, which is a part of SWEMIX Group. “With the relocation in Sweden and the new facility in Poland, all of the steps of our resolved investments in capacity expansion are now complete, and we are ready for the upcoming expansion to support electrification and energy efficiency in both of our business areas,”

Medivir to present at the Carlsquare Equity Research Investor Day

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announces that the company will present at the Carlsquare Equity Research Investor Day, today December 6, 2023.   CEO Jens Lindberg will present at 14.30 CET, with focus on the latest developments and the company's future plans. This will include, among other things, the company's rights issue and how it aims to ensure the highest possible speed and momentum in the development program for fostrox with the aim of

There are no items matching the current filter
There are no more items matching the current filter
Back to top